Antibody drugs that are in testing and were administered to President Trump could significantly reduce the death rate from Covid-19 once they are approved by regulators and more widely available, billionaire philanthropist Bill Gates said Tuesday.
The drugs, in a class of medicines known as monoclonal antibodies, have shown promise in early-stage patients with Covid-19. “That’s actually pretty exciting,” Mr. Gates told The Wall Street Journal’s CEO Council Summit. “The reduction in death rate there could be pretty high, and those will be out in volume by the end of the year, at least in the rich countries.”
